| __timestamp | Arrowhead Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 18372000 |
| Thursday, January 1, 2015 | 57410147 | 15419000 |
| Friday, January 1, 2016 | 41454452 | 23844000 |
| Sunday, January 1, 2017 | 31690298 | 40376000 |
| Monday, January 1, 2018 | 52968505 | 75247000 |
| Tuesday, January 1, 2019 | 81048686 | 89017000 |
| Wednesday, January 1, 2020 | 128874979 | 114764000 |
| Friday, January 1, 2021 | 206342000 | 113864000 |
| Saturday, January 1, 2022 | 297307000 | 130991000 |
| Sunday, January 1, 2023 | 353188000 | 184353000 |
| Monday, January 1, 2024 | 505870000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated have demonstrated contrasting strategies in their R&D investments.
Since 2014, Arrowhead Pharmaceuticals has consistently increased its R&D spending, culminating in a remarkable 2,086% growth by 2023. This strategic focus underscores their dedication to pioneering advancements in RNA interference therapeutics.
Corcept Therapeutics, on the other hand, has shown a more measured increase in R&D expenses, with a 902% rise over the same period. Their focus on developing treatments for severe metabolic and psychiatric disorders reflects a balanced approach to innovation.
While Arrowhead's aggressive investment strategy highlights their ambition, Corcept's steady growth suggests a calculated path to sustainable innovation.
R&D Insights: How Merck & Co., Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Comparing Innovation Spending: Pfizer Inc. and Corcept Therapeutics Incorporated
R&D Insights: How Neurocrine Biosciences, Inc. and Corcept Therapeutics Incorporated Allocate Funds
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: Corcept Therapeutics Incorporated and Opthea Limited
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Veracyte, Inc.
R&D Spending Showdown: Apellis Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.